Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2022 Earnings Call Transcript
Operator: Welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2022 Conference Call. Please be advised that this call is being recorded at the company's request.
Oncolytics Biotech Inc (ONCY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 37,271 | $60,752 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 112,600 | $184 | +358% | 0% |
| 3. | Millennium Management Israel Englander | 25,689 | $42 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 183,783 | $299,566 | 0.03% | |
| 2. | 104,210 | $169,862 | 0% | |
| 3. | 46,434 | $76,000 | 0% | |
| 4. | 36,861 | $66,973 | 0% | |
| 5. | 40,000 | $65,200 | 0% |
News See All
Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren't Crazy About It But Hedge Funds Love It
To the average investor, there are tons of indicators shareholders can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)
At the moment, there are tons of methods market participants can use to watch Mr. Market. A pair of the most useful are hedge fund and insider trading sentiment.
Is Coronado Biosciences Inc (CNDO) Going to Burn These Hedge Funds?
If you'd ask most market participants, hedge funds are viewed as worthless, old financial vehicles of years past.
Should You Avoid GTx, Inc. (GTXI)?
Is GTx, Inc. (NASDAQ:GTXI) a superb investment right now? Investors who are in the know are taking a pessimistic view.
Oncolytics Biotech, Inc. (USA) (ONCY): This High-Risk, High-Reward Biotech Is Worth a Look
Let me preface this by saying that investing in the biotech sector can sometimes be nothing more than speculating.
This Metric Says You Are Smart to Buy Curis, Inc. (CRIS)
Curis, Inc. (NASDAQ:CRIS) was in 10 hedge funds' portfolio at the end of March. CRIS investors should be aware of an increase in hedge fund interest in recent months.
Oncolytics Biotech, Inc. (USA) (ONCY): This Promising Biotech Can Triple
Cancer is one of the deadliest challenges that humans face today. Different forms of cancer have taken millions of lives all around the world.
Should You Buy Progenics Pharmaceuticals, Inc. (PGNX)?
In the eyes of most market participants, hedge funds are viewed as slow, outdated investment tools of the past.
Billionaire Hedge Funds
